"2023's Remarkable Medical Breakthroughs: Drug Approvals, Vaccines, and Innovations"
GoodRx Health has compiled a list of the most notable drug and vaccine approvals of 2023, selected by pharmacists. The list includes Paxlovid for COVID-19, Arexvy, Abrysvo, and Beyfortus for RSV, Opill for contraception, Zurzuvae for postpartum depression, Leqembi for Alzheimer's disease, OTC naloxone for opioid overdoses, Zepbound for chronic weight management, Roctavian for hemophilia A, and Casgevy and Lyfgenia for sickle cell disease. These approvals are seen as meaningful steps forward in improving human health and accessibility to treatments.